Key result
Psoriasis is linked to thicker epicardial adipose tissue, which correlates with BMI, CRP, and SBP.
Why the study?
Psoriasis and psoriatic arthritis affect the cardiovascular system, prompting investigation into the relationship between epicardial adipose tissue thickness and anthropometric, laboratory, and clinical variables.
Is epicardial adipose tissue thickness increased in patients with psoriasis and psoriatic arthritis compared to healthy controls, and does it correlate with clinical and metabolic parameters?
Is epicardial adipose tissue thickness increased in patients with psoriasis and psoriatic arthritis compared to healthy controls, and does it correlate with clinical and metabolic parameters?
Epicardial adipose tissue thickness is increased in patients with psoriasis and correlates with BMI, CRP, and systolic blood pressure, suggesting a link between systemic inflammation and cardiovascular risk markers.
Answers are grounded in this paper and cite their sources.
Enhanced cardiovascular monitoring may be considered for psoriasis patients; extends prior evidence linking inflammation to epicardial adipose tissue but leaves open causal pathways.
Background: Psoriasis and psoriatic arthritis (PsA) are chronic inflammatory diseases that affect not only the skin and joints but also the cardiovascular system. Aim: To investigate the relationship between epicardial adipose tissue (EAT) thickness and anthropometric measurements, laboratory parameters, and clinical variables in patients with psoriasis and PsA. Methods: This cross-sectional study included 65 patients with psoriasis vulgaris (with or without PsA) and 54 healthy controls. Demographic, clinical, and laboratory data of the participants were recorded. EAT, left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), interventricular septum thickness (IVS), and ejection fraction (EF) were measured by echocardiography. Associations between EAT thickness and patient parameters were evaluated using Spearman correlation and multivariate linear regression analyses. Results: The mean ages of the patient and control groups were 43.88 ± 13.1 years and 44.81 ± 12.88 years, respectively. Low-density lipoprotein cholesterol, LVESD, and IVS were significantly higher in the control group compared with psoriasis patients ( P = 0.021, P < 0.001, P < 0.001, respectively). C-reactive protein (CRP) levels ( P < 0.001), systolic blood pressure ( P < 0.001), diastolic blood pressure ( P = 0.023), and EAT thickness ( P < 0.001) were significantly higher in the patient group. Disease duration ( P = 0.028) and PASI ( P = 0.012) were significantly greater in psoriasis patients with PsA. EAT positively correlated with body mass index (BMI) ( r = 0.307, P = 0.024), CRP ( r = 0.344, P < 0.001), and systolic blood pressure ( r = 0.185, P = 0.044). Conclusions: EAT thickness was higher in patients with psoriasis than in control participants. EAT positively correlated with BMI, CRP, and systolic blood pressure.
No takes yet. Share an insight, caveat, or question.
Gürok et al. (2026) studied this question. Epicardial adipose tissue thickness was higher in psoriasis patients and positively correlated with BMI, CRP, and systolic blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: